India Diagnostic & Therapeutic Antibodies Market Review Now Available at MarketPublishers.com
London, UK (PRWEB) January 25, 2012
India’s market for both diagnostic and therapeutic antibodies is expected to grow at a significant rate in upcoming years. More than 60% of the total antibodies market is currently dominated by diagnostic antibodies segment, which is more mature, has lower entry barriers and is extremely price sensitive. The country’s market for therapeutic antibodies, on the other hand, is still in its infancy and more than half of the globally launched therapeutic monoclonal antibodies are currently not even available. However, the market for therapeutic antibodies is expected to explode, with a CAGR of 27% in the next five years, driven by a rise in healthcare expenditures, increasing affordability, and a number of new product launches.
New research report “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” delivered by IMARC Group has been recently published by Market Publishers Ltd.
Report Details:
Title: Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016
Published: January, 2012
Pages: 78
Price: US$ 1,000
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/indian_diagnostic_therapeutic_antibodies_market_report_forecast_2011_2016.html
The research report provides true and unbiased insights into the antibodies market in India. It enhances understanding of not only the market trends, key drivers & restraints, but also the competitive landscape and outlook of the market through 2016.
Market segments covered include: HIV, hepatitis B, hepatitis C, tuberculosis, dengue, syphilis and oncology.
Report Contents:
1 Market Definitions & Methodology
2 Executive Summary
3 Indian Antibodies Market
4 Antibody Based Diagnostics Market in India
4.1 Industry Analysis
4.1.1 Strengths
4.1.2 Weaknesses
4.1.3 Opportunities
4.1.4 Threats
4.2 Technological & Regulatory Assessment
4.2.1 Technological Assessment
4.2.2 Regulatory Assessment
4.3 Market Analysis
4.3.1 Current & Future Sales Trends
4.3.2 Market Segments by Usage
4.3.2.1 HIV Diagnostics: Current Trends & Forecast
4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast
4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast
4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast
4.3.2.5 Dengue Diagnostics: Current Trends & Forecast
4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast
4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast
4.3.2.8 Oncology Diagnostics: Current Trends & Forecast
5 Therapeutic Antibodies Market in India
5.1 Industry Analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2 Technological & Regulatory Assessment
5.2.1 Technological Assessment
5.2.2 Regulatory Assessment
5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India
5.4 Market Analysis
5.4.1 Current & Future Sales Trends
5.4.2 Sales Breakup by Molecule
5.4.3 Sales by Indication
5.5 Evaluation of Top Monoclonal Antibodies
5.5.1.1 Avastin
5.5.1.2 Herceptin
5.5.1.3 Rituxan/Mabthera
5.5.1.4 Remicade
5.5.1.5 Humira
5.6 Biosimilar Case Studies
5.6.1 Reditux
5.6.2 Grafeel
5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes
List of Figures
Figure 3-1: India – Antibodies Market Forecast, 2010-2016
Figure 3-2: India – Antibodies Market Breakup by Segment Forecast (in %), 2010-2016
Figure 4-1: India – Overview of Elisa and Rapid Tests
Figure 4-2: India – In-Vitro Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-3: India – Immunodiagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-4: India – Immunodiagnostics Market Forecast: Breakup by Indication (in %), 2010 & 2016
Figure 4-5: India – HIV Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-6: India – HIV Diagnostics Market: Volume Share by Lab (in %), 2010
Figure 4-7: India – HIV Diagnostics Market: Value & Volume Share of Various Tests (in %), 2010
Figure 4-8: India – Hepatitis B Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-9: India – Hepatitis B Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4-10: India – Hepatitis C Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-11: India – Hepatitis C Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4-12: India – Tuberculosis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-13: India – Tuberculosis Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4-14: India – Dengue Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-15: India – Dengue Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4-16: India – Pregnancy Market Forecast (in INR Million), 2010-2016
Figure 4-17: India – Syphilis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4-18: India – Syphilis Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4-19: India – Cancer Diagnostics Market Forecast (in INR Million), 2010-2016
…
More new market research reports by the publisher can be found at IMARC Group page.
###
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with more information? It is extremely helpful for me.